Search Within

Epidemiology and Biostatistics

Formats
  1. Journal Article (6498)
  2. Meeting Abstract (3316)
  3. Editorial (119)
  4. Review (95)
  5. Research Letter (84)
  6. Correspondence (80)
  7. Conference Paper (55)
  8. Miscellaneous (53)
  9. Book Section (45)
  10. Guidelines (13)
  11. Book Whole (5)
Groups
  1. Biostatistics Service (6660)
  2. Department of Medicine (5011)
  3. Population Sciences Research Program (4940)
  4. Surgery (3714)
  5. Survivorship Research (3652)
  6. Solid Tumor Oncology Division (3356)

More Groups

People
  1. Mithat Gonen (1033)
  2. Andrew Vickers (890)
  3. Sean Devlin (615)
  4. Katherine Panageas (519)
  5. Sujata Patil (511)
  6. Nikolaus Schultz (491)

More People

Years
  1. 2025 (319)
  2. 2024 (666)
  3. 2023 (692)
  4. 2022 (732)
  5. 2021 (610)
  6. 2020 (625)

More Years

Publications
  1. Journal of Clinical Oncology (1401)
  2. Blood (578)
  3. Annals of Surgical Oncology (464)
  4. Cancer Research (274)
  5. International Journal of Radiation Oncology, Biology, Physics (259)
  6. Clinical Cancer Research (252)

More Publications

Publishers
  1. American Society of Clinical Oncology (1517)
  2. Elsevier Inc. (1212)
  3. Springer (930)
  4. American Association for Cancer Research (766)
  5. Elsevier Science, Inc. (692)
  6. American Society of Hematology (647)

More Publishers

Results (10363)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial results from the ASH research collaborative's COVID-19 outcomes in myeloma and the impact of vaccines (COSMIC): A decentralized, real-world evidence study for patients with multiple myeloma to monitor outcomes related to COVID-19 vaccines and infections
    Meeting Abstract

    Usmani, S. Z.; Semmel, E. A.; James, S.; Wood, W. A.; Schroeder, M. A.; Chung, D. J.; Rosenberg, A. S.; Zonder, J. A.; Rubinstein, S. M.; D'Souza, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Outcomes of therapies following discontinuation of non-covalent Bruton's tyrosine kinase inhibitors for patients with chronic lymphocytic leukemia and Richter transformation: Results from an international, multicenter study
    Meeting Abstract

    Thompson, M. C.; Bhat, S. A.; Jurczak, W.; Patel, K.; Shah, N. N.; Woyach, J. A.; Coombs, C. C.; Eyre, T. A.; Danecki, M.; Dlugosz-Danecka, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in treatment-naive chronic lymphocytic leukemia: 5-Year follow up, retreatment outcomes, and Impact of MRD kinetics (ΔMRD400)
    Meeting Abstract

    Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K. L.; Slupe, N.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Genomic characterization and classification of BCL6 rearranged follicular lymphomas
    Meeting Abstract

    Amallraja, A.; Gundem, G.; Domenico, D.; Ossa, J. E. A.; Aypar, U.; Baik, J.; Kluk, M.; Sethi, S.; Lopez, K.; Qualls, D. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • High grade B-cell lymphoma with MYC/BCL6-rearrangements (R) may have inferior outcomes compared to BCL2-R disease
    Meeting Abstract

    Healton, S. E.; Luttwak, E.; Rivas-Delgado, A.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Derivation and external validation of a venous thromboembolism risk prediction model in patients with acute lymphoblastic leukemia receiving asparaginase therapy
    Meeting Abstract

    Anderson, D. R.; Gangaraju, R.; Sedhom, W.; Hamulyak, E. N.; Wang, T. F.; O'Dwyer, K. M.; Carney, B. J.; Muthiah, C.; Liedtke, M.; Badar, T.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Predictive modeling of clonal hematopoiesis across diverse cohorts
    Meeting Abstract

    Batchi-Bouyou, A. L.; Tran, D.; Raddatz, M.; Gao, T.; Vlasschaert, C.; Sharber, B.; Liu, J.; Petrone, G.; Chan, I. C. C.; Beeler, J. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Venous thromboembolism incidence in patients with cancer and factor XI deficiency
    Meeting Abstract

    Chrysafi, P.; Derkach, A.; Zwicker, J. I.; Leader, A.
    Blood (2024)

    Fulltext@MSK | Save
  • Imaging predictors of intracerebral hemorrhage in patients with brain tumors treated with anticoagulation
    Meeting Abstract

    Barnea, R.; Naftali, J.; Hamulyak, E. N.; Peseski, A. M.; Wang, T. F.; Kreuziger, L. B.; Iyengar, V.; Carney, B. J.; Özdemir, B.; Serrano, R. D. C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD)-adapted duration of front-line venetoclax and obinutuzumab treatment for fit patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Roeker, L.; Mato, A. R.; Zelenetz, A. D.; Park, J. H.; Geyer, M. B.; Derkach, A.; Nemirovsky, D.; Islam, P.; Falchi, L.; Palomba, M. L.; more...
    Blood (2024)

    Fulltext@MSK | Save